Proposed improvements to the Therapeutic Goods Advertising Code

Closed 18 Jun 2021

Opened 7 May 2021


The Therapeutic Goods Administration (TGA) is seeking feedback on options to improve the Therapeutic Goods Advertising Code (No.2) 2018 (the Code). The Code is the compliance standard that prescribes the minimum requirements for the lawful advertising of therapeutic goods to the general public in Australia.

The proposed improvements are aimed at increasing advertisers’ understanding of the requirements of the Code, ensuring provisions work as intended, and improving advertising compliance. The proposed improvements consider the need to minimise unnecessary compliance costs while continuing to ensure that advertising does not contribute to any unsafe or improper use of advertised products.

Consultation Paper

The consultation paper provides details about proposed improvements to the Code and poses questions to guide responses to the consultation.

Consultation paper – Proposed improvements to the Therapeutic Goods Advertising Code

Why we are consulting

The Code is an important instrument for a range of stakeholders including advertisers, manufacturers, suppliers and retailers; relevant industry associations; health professionals and peak bodies; and consumers and consumer representative groups. The TGA has listened to stakeholder concerns about aspects of the current Code. With the potential for serious consequences for non-compliance, it is important that the Code is contemporary and clear. Stakeholder feedback on the options presented here will assist the TGA with improving the Code.

Consultation Scope

In this consultation paper we have proposed different mechanisms for improving the Code. For some provisions we have proposed minor wording changes and the addition of new definitions and notes to improve clarity. For others, we are seeking feedback on options for combining provisions and other more significant changes.


  • Aboriginal and Torres Strait Islander People
  • Seniors
  • Men
  • Women
  • Carers and guardians
  • Families
  • Parents
  • Young people
  • Academics
  • Non-government organisations
  • State government agencies
  • Health professionals
  • Health workforce
  • General public
  • Community groups
  • Businesses
  • Contracted Service Providers
  • Aged care service providers
  • Aged care workforce
  • Aged care professionals
  • Complementary medicines
  • Over-the-counter medicines
  • Medical Devices & IVDs


  • Hospitals
  • e-Health
  • Health technology
  • Medicare
  • Legislation
  • Pharmaceutical benefits
  • Health insurance
  • Rural health services
  • Regulatory policy
  • Women's health
  • Children's health
  • Learning and development
  • Dementia
  • Home Care
  • Aged Care
  • Residential Aged Care
  • Short-Term Restorative Care
  • Chronic disease
  • Communicable diseases
  • Mental health
  • Drugs and substance abuse
  • Aboriginal and Torres Strait Islander health
  • Preventative health
  • Dental health
  • Non-prescription medicines
  • Strategic Policy